Daratumumab,Talquetamab,Teclistamab,Pomalidomide
janssen,genmab
['teclistamab', 'multiplemyeloma', 'trimm-2', 'janssen']
#janssen #pharmaceuticals announced the phase 1b trimm-2 study results of #teclistamab in patients with relapsed or refractory #multiplemyeloma #pharma #pharmaeutical #healthcare #health #blogs #conferences #news #eha2022 #eha22 #cancer #patientcare
iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma